Apyx medical corporation to release first quarter of fiscal year 2024 financial results on may 9, 2024

Clearwater, fla.--(business wire)--apyx medical corporation (nasdaq:apyx) (the “company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as renuvion®, today announced that financial results for the first quarter of fiscal year 2024 will be released before the market opens on thursday, may 9th. management will host a conference call at 8:00 a.m. eastern time on may 9th to discuss the results of the quarter, and to host a question and answer sessi.
APYX Ratings Summary
APYX Quant Ranking